In addition, these molecular actions lead to excessive insulin-like growth factor (IGF) pathway activity, which is mediated in BC cells by molecular signaling through other mechanisms and estrogen receptor 2 (ESR2) pathways [119,120]. The gene discussed is IGF1; the disease is breast cancer.